© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Together is global

Together is global

Technology / Mergers and Acquisitions

 We have an excellent track record of M&A technology transactions

Our technology department team has extensive experience in guiding and managing technology companies’ M&A transactions, from planning the structure of the transaction, conducting the negotiations, drafting of the entire set of agreements, working opposite the various government authorities and financing entities whose approvals are required in order to proceed with the transaction, to consummating and implementing the transaction.

 

Over the years, Barnea has been involved in a variety of sale transactions of Israeli technology companies in diverse sectors, including communications companies, medical instrumentation companies, hardware and software companies, internet companies and more.

 

The head of our technology department, Micky Barnea and Dr. Dotan Baruch have excellent reputations and vast experience in advising and guiding complex large-scale technology M&A transactions.

 

Micky Barnea and Dr. Dotan Baruch are considered prominent leaders in the high-tech sector by Israeli and international rating directories. 

 

Back to Technology

News and updates - Technology / Mergers and Acquisitions:


November 18, 2019

Representing Cymplify in Acquisition by Check Point

Our firm represented the IoT security company Cymplify in its acquisition by NASDAQ-listed cloud security company Check Point Software Technologies Ltd. for USD 5 million.

October 16, 2019

Representing German Fund Mercura in Investment in Israeli Startup 3DSignals

Our firm represented the German fund Mercura in its investment in 3DSignals. This Israeli startup enables the monitoring of production floor performance. The investment follows the company's rapid growth in the German market.

September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

Technology / Mergers and Acquisitions

 We have an excellent track record of M&A technology transactions

Our technology department team has extensive experience in guiding and managing technology companies’ M&A transactions, from planning the structure of the transaction, conducting the negotiations, drafting of the entire set of agreements, working opposite the various government authorities and financing entities whose approvals are required in order to proceed with the transaction, to consummating and implementing the transaction.

 

Over the years, Barnea has been involved in a variety of sale transactions of Israeli technology companies in diverse sectors, including communications companies, medical instrumentation companies, hardware and software companies, internet companies and more.

 

The head of our technology department, Micky Barnea and Dr. Dotan Baruch have excellent reputations and vast experience in advising and guiding complex large-scale technology M&A transactions.

 

Micky Barnea and Dr. Dotan Baruch are considered prominent leaders in the high-tech sector by Israeli and international rating directories. 

 

Back to Technology

News and updates - Technology:


November 18, 2019

Representing Cymplify in Acquisition by Check Point

Our firm represented the IoT security company Cymplify in its acquisition by NASDAQ-listed cloud security company Check Point Software Technologies Ltd. for USD 5 million.

October 16, 2019

Representing German Fund Mercura in Investment in Israeli Startup 3DSignals

Our firm represented the German fund Mercura in its investment in 3DSignals. This Israeli startup enables the monitoring of production floor performance. The investment follows the company's rapid growth in the German market.

September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

Enter your email for newsletter sign up: